Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores
University of Manchester · AstraZeneca (United Kingdom)
Abstract
The Aurora/Ipl1 family of protein kinases plays multiple roles in mitosis and cytokinesis. Here, we describe ZM447439, a novel selective Aurora kinase inhibitor. Cells treated with ZM447439 progress through interphase, enter mitosis normally, and assemble bipolar spindles. However, chromosome alignment, segregation, and cytokinesis all fail. Despite the presence of maloriented chromosomes, ZM447439-treated cells exit mitosis with normal kinetics, indicating that the spindle checkpoint is compromised. Indeed, ZM447439 prevents mitotic arrest after exposure to paclitaxel. RNA interference experiments suggest that these phenotypes are due to inhibition of Aurora B, not Aurora A or some other kinase. In the…
Citation impact
- FWCI
- 22.17
- Percentile
- 100%
- References
- 35
Authors
9Topics & keywords
- Aurora B kinase
- Spindle checkpoint
- Kinetochore
- Mad2
- Cell biology
- Anaphase
- Aurora kinase
- BUB1